Inspire Investing’s Cellectis CLLS Stock Holding History

Inspire Investing’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9	Hold	6	–	–	﹤0.01%	1274
2026 Q2	$18	Hold	6	–	–	﹤0.01%	1257
2026 Q1	$19	Sell	6 -2	-25%	-$8	﹤0.01%	1098
2025 Q4	$37	Buy	+8	New	+$33	﹤0.01%	1083
2020 Q2	–	Sell	-25	Closed	–	–	539
2020 Q1	$0	Buy	+25	New	+$373	﹤0.01%	752
2018 Q1	–	Sell	-43	Closed	-$1K	–	295
2017 Q4	$1K	Buy	+43	New	+$1.17K	﹤0.01%	851

Other funds holding CLLS

Walleye Partners Madison, Wisconsin $89M AUM 5.66% 1-Year Est. Return

PIS

POM Investment Strategies Raleigh, North Carolina $124M AUM 9.91% 1-Year Est. Return

Inspire Investing's CLLS Position: Q3 2026 in Review

Inspire Investing held its Cellectis (CLLS) position steady in Q3 2026 at 6 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

Inspire Investing first reported a position in CLLS in Q4 2017 and has held it in 6 quarters since. The position peaked at $1K in Q4 2017. 3 funds tracked by Wall St. Rank hold CLLS as of Q3 2026.

Inspire Investing held 6 shares of Cellectis worth $9 as of Q3 2026.
Inspire Investing left its Cellectis share count unchanged in Q3 2026.
Cellectis made up ﹤0.01% of Inspire Investing's portfolio in Q3 2026, its #1274 holding.
Inspire Investing first reported a position in Cellectis in Q4 2017 and has held it in 6 quarters since.
Inspire Investing's Cellectis position peaked at $1K in Q4 2017.
3 funds tracked by Wall St. Rank held Cellectis as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.